Risk Assessment Report of a new psychoactive substance: 1-cyclohexyl-4-(1,2-diphenylethyl)piperazine (MT-45)

Series type: Risk assessments

Summary

This report presents the data and findings of the risk assessment on the new psychoactive substance, MT-45, that was conducted by the Scientific Committee of the EMCDDA. Concerns over the availability and use of this stimulant drug in the European Union led to an assessment of the health and social risks posed by the substance, and, consequently, its control across the EU Member States.

Download as PDF

Table of contents

  • Risk Assessment Report of a new psychoactive substance: 1-cyclohexyl-4-(1,2-diphenylethyl)piperazine (MT-45)
  • Technical report on 1-cyclohexyl-4-(1,2-diphenylethyl)piperazine (MT-45)
  • Participants of the risk assessment meeting
Pages: 
72
Price: 
free